Variability, but Not Concentration, of Neuromelanin in the Substantia Nigra Is Associated With Individual Differences in Interference Control
Human Brain Mapping · 2026-11 · 47 (16)
DOI: 10.1002/hbm.70663 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, online erschienen am 09.11.2026. Verfasst von Shuhui Lyu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Brain Science and Mental Health, Faculty of Psychology, Shandong Normal University, Jinan, China. Hauptthemen laut MEDLINE: Melanins, Substantia Nigra, Individuality, Conflict, Psychological. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Shandong Province.
Abstract (Originalsprache)
Interference control—the ability to suppress distracting information while selecting task‐relevant responses—relies on dopaminergic modulation of fronto‐striatal circuits. Although pharmacological evidence shows that transient dopaminergic enhancement can reduce interference, it remains unclear whether stable, trait‐like properties of the dopaminergic system constrain individual differences in control efficiency. The present study examined whether the concentration of the neuromelanin signal (NM‐Mean), and/or its variability, indexed by the standard deviation of the neuromelanin‐sensitive MRI contrast‐to‐noise ratio (NM‐SD), within the substantia nigra is associated with performance in the Flanker conflict task. Sixty healthy young adults completed the task. Neuromelanin CNR maps were registered to MNI152 standard space for ROI definition, and voxel‐wise CNR values within the SN–VTA region were extracted in native space to derive NM‐Mean and NM‐SD. NM‐Mean, indexing overall neuromelanin concentration, was not related to behavioral performance. In contrast, lower NM‐SD, reflecting more homogeneous dopaminergic integrity, was associated with smaller Flanker interference effects but was unrelated to conflict adaptation across trials. Statistically controlling for voxel size rendered the effect size no longer significant, but a trend remained. These findings provide limited and preliminary evidence that individual differences in dopaminergic signal reliability, rather than overall dopamine quantity, contribute to variability in cognitive control. Although NM‐SD is sensitive to acquisition‐related factors such as spatial resolution, the observed attenuation of its association with interference control after controlling for voxel size suggests that its behavioral relevance may reflect a mixture of biological variability and methodological influences rather than a clear trait‐like property of the dopaminergic system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Brain Science and Mental Health, Faculty of Psychology, Shandong Normal University, Jinan, China.
ORCID-Profile: Shuhui Lyu, Hongchi Zhang, Jiaqi Gao, Kangcheng Wang, Lorenza Colzato, Bernhard Hommel
Förderung
- Government of Shandong Province
Zitieren
APA
Lyu, S., Zhang, H., Yan, J., Gao, J., Wang, K., Colzato, L., & Hommel, B. (2026). Variability, but Not Concentration, of Neuromelanin in the Substantia Nigra Is Associated With Individual Differences in Interference Control. Human Brain Mapping, 47(16). https://doi.org/10.1002/hbm.70663
Vancouver
Lyu S, Zhang H, Yan J, Gao J, Wang K, Colzato L, et al. Variability, but Not Concentration, of Neuromelanin in the Substantia Nigra Is Associated With Individual Differences in Interference Control. Human Brain Mapping. 2026;47(16). doi:10.1002/hbm.70663
BibTeX
@article{Lyu2026,
author = {Lyu, Shuhui and Zhang, Hongchi and Yan, Jimin and Gao, Jiaqi and Wang, Kangcheng and Colzato, Lorenza and Hommel, Bernhard},
title = {Variability, but Not Concentration, of Neuromelanin in the Substantia Nigra Is Associated With Individual Differences in Interference Control},
journal = {Human Brain Mapping},
year = {2026},
volume = {47},
number = {16},
doi = {10.1002/hbm.70663}
}
EUVIMED